Gene: CCDC97
Official Full Name: coiled-coil domain containing 97provided by HGNC
Gene Summary: Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23789 | CCDC97 Knockout cell line (HeLa) | Human | CCDC97 | 1:3~1:6 | Negative | Online Inquiry |
KO23790 | CCDC97 Knockout cell line (HCT 116) | Human | CCDC97 | 1:2~1:4 | Negative | Online Inquiry |
KO23791 | CCDC97 Knockout cell line (HEK293) | Human | CCDC97 | 1:3~1:6 | Negative | Online Inquiry |
KO23792 | CCDC97 Knockout cell line (A549) | Human | CCDC97 | 1:3~1:4 | Negative | Online Inquiry |
CCDC97 Gene Knockout Cell Lines are precision-engineered cellular models designed for the study of gene function and associated biological pathways. These cell lines have been meticulously developed to contain targeted disruptions in the CCDC97 gene, allowing researchers to investigate its role in various cellular processes, including cell proliferation, differentiation, and apoptosis, within a controlled environment.
The key mechanism through which these knockout cell lines operate is the complete ablation of the CCDC97 gene, which plays a significant role in cytoskeletal organization and cellular signaling. By utilizing CRISPR/Cas9 technology, researchers can ascertain the physiological and pathological consequences of CCDC97 loss, thus shedding light on its involvement in diseases such as cancer and neurodegenerative disorders. This approach allows for the elucidation of cellular pathways, facilitating the discovery of potential therapeutic targets.
The scientific importance of CCDC97 knockout cell lines spans both research and clinical applications. In research settings, these cell lines are invaluable for elucidating gene function, validating drug targets, and conducting high-throughput screening for potential therapeutic agents. Clinically, understanding the role of the CCDC97 gene can lead to novel insights in personalized medicine and the development of gene-based therapies.
Compared to conventional cell lines that express the CCDC97 gene, the knockout variants offer unique advantages. They enable direct comparative studies, providing insights into gene-specific effects without the confounding influence of CCDC97 expression. This specificity enhances experimental accuracy and supports robust data generation.
For researchers and clinicians alike, CCDC97 Gene Knockout Cell Lines represent a cutting-edge tool that streamlines experimentation and accelerates the pace of discovery in genetic and biomedical research. Our company stands at the forefront of biotechnology, dedicated to providing high-quality biological products that empower scientific investigation and innovation. With expertise in gene editing and cell line development, we ensure that our offerings meet the highest standards of reliability and performance, enabling our customers to unlock new scientific possibilities.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.